Integral Derivatives’s Colgate-Palmolive CL Stock Holding History

Integral Derivatives’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2.67M	Buy	+37,200	New	+$2.68M	0.07%	93
2017 Q3	–	Sell	-40,000	Closed	-$2.96M	–	1148
2017 Q2	$2.96M	Buy	40,000 +30,600	+326%	+$2.27M	0.06%	217
2017 Q1	$688K	Buy	+9,400	New	+$658K	0.01%	637
2016 Q2	–	Sell	-54,200	Closed	-$3.83M	–	963
2016 Q1	$3.83M	Buy	+54,200	New	+$3.61M	0.13%	124
2015 Q4	–	Sell	-15,000	Closed	-$952K	–	1081
2015 Q3	$952K	Buy	15,000 +5,000	+50%	+$327K	0.03%	508
2015 Q2	$654K	Buy	+10,000	New	+$678K	0.02%	651
2014 Q3	–	Sell	-14,500	Closed	-$989K	–	1407
2014 Q2	$989K	Buy	14,500 +10,500	+263%	+$704K	0.02%	692
2014 Q1	$259K	Sell	4,000 -9,900	-71%	-$624K	﹤0.01%	1111
2013 Q4	$906K	Buy	+13,900	New	+$890K	0.01%	822

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Integral Derivatives's CL Position: Q1 2018 in Review

Integral Derivatives sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 10,325 shares — an estimated $743K sold.

Integral Derivatives first reported a position in CL in Q4 2013 and held it in 8 quarters. The position peaked at $3.91M in Q4 2014. 1,438 funds tracked by Wall St. Rank hold CL as of Q1 2018.

Integral Derivatives reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 10,325 Colgate-Palmolive shares in Q1 2018, an estimated $743K.
Integral Derivatives first reported a position in Colgate-Palmolive in Q4 2013 and held it in 8 quarters.
Integral Derivatives's Colgate-Palmolive position peaked at $3.91M in Q4 2014.
1,438 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.